Analyze Diet
The Veterinary clinics of North America. Equine practice1985; 1(2); 335-352; doi: 10.1016/s0749-0739(17)30759-9

Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.

Abstract: The rational therapy of cardiovascular disease in horses requires a thorough knowledge of the pharmacology and pharmacokinetics of several specific drugs (digitalis, digoxin). Calcium solutions, dopamine, and dobutamine are frequently used to treat congestive heart failure in horses. Quinidine, procainamide, lidocaine, and propranolol are used to treat a variety of supraventricular and ventricular arrhythmias. Furosemide, a highly potent loop diuretic, is used to eliminate edema and promote diuresis. A thorough understanding of the applied pharmacology, dosage recommendations, toxicity, and practical considerations must be attained before these drugs can be used effectively.
Publication Date: 1985-08-01 PubMed ID: 3878193DOI: 10.1016/s0749-0739(17)30759-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research examines the effective usage and understanding of pharmacology and pharmacokinetics of drugs (like digitalis, digoxin, etc.) used to treat cardiac disease in horses. It stresses the importance of understanding the applied pharmacology, dosage recommendations, potential toxicity, and practical considerations before efficient usage.

Understanding pharmacology and pharmacokinetics

The article stresses the importance of understanding the pharmacology, which is the study of how drugs interact with a living body, and pharmacokinetics, which is the study of how a drug is absorbed, distributed, metabolized, and excreted by the body. This knowledge is key to effectively treating cardiovascular disease in horses. Specific drugs mentioned include digitalis and digoxin.

  • Digitalis and digoxin: These drugs have been traditionally used to treat various heart conditions in humans and are being used in equine veterinary practice.

Treatment of congestive heart failure

Concentrates on the use of certain drugs to treat congestive heart failure in horses. These include calcium solutions, dopamine, and dobutamine.

  • Calcium solutions: These help maintain proper heart rhythm.
  • Dopamine and dobutamine: Used to increase heart rate and strength of heart muscle contraction, which can increase cardiac output and improve blood supply.

Dealing with arrhythmias

Indicates that the drugs quinidine, procainamide, lidocaine, and propranolol are used to treat a variety of supraventricular and ventricular arrhythmias in horses.

  • Supraventricular and ventricular arrhythmias: These are abnormal heart rhythms that originate either in the upper or lower chambers of the heart.
  • Quinidine, procainamide, lidocaine, and propranolol: These drugs work by correcting irregular heartbeats.

Furosemide for Edema and Diuresis

Furosemide, a highly potent loop diuretic, is mentioned as a standard treatment to eliminate edema and promote diuresis in horses suffering from heart disease.

  • Edema: Swelling caused by excess fluid trapped in body’s tissues, which can result from heart disease.
  • Diuresis: The increased production of urine, which can prevent fluid buildup in horses with heart issues.
  • Furosemide: A potent diuretic that helps get rid of excess fluid and salt in the body.

Need for thorough understanding

Emphasizes the absolute necessity for practitioners to have a deep understanding of applied pharmacology, dosage recommendations, toxicity, and practical considerations before these drugs can be used effectively in treating horses with heart disease.

Cite This Article

APA
Muir WW, McGuirk SM. (1985). Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses. Vet Clin North Am Equine Pract, 1(2), 335-352. https://doi.org/10.1016/s0749-0739(17)30759-9

Publication

ISSN: 0749-0739
NlmUniqueID: 8511904
Country: United States
Language: English
Volume: 1
Issue: 2
Pages: 335-352

Researcher Affiliations

Muir, W W
    McGuirk, S M

      MeSH Terms

      • Administration, Oral
      • Animals
      • Arrhythmias, Cardiac / drug therapy
      • Arrhythmias, Cardiac / veterinary
      • Cardiovascular Agents / metabolism
      • Cardiovascular Agents / pharmacology
      • Cardiovascular Agents / therapeutic use
      • Digoxin / pharmacology
      • Digoxin / therapeutic use
      • Diuretics / therapeutic use
      • Dobutamine / pharmacology
      • Dobutamine / therapeutic use
      • Dopamine / pharmacology
      • Dopamine / therapeutic use
      • Drug Administration Schedule
      • Edema / drug therapy
      • Edema / etiology
      • Heart Diseases / drug therapy
      • Heart Diseases / metabolism
      • Heart Diseases / physiopathology
      • Heart Diseases / veterinary
      • Heart Failure / complications
      • Heart Failure / therapy
      • Heart Failure / veterinary
      • Heart Rate / drug effects
      • Hemodynamics / drug effects
      • Horse Diseases / drug therapy
      • Horse Diseases / metabolism
      • Horse Diseases / physiopathology
      • Horses
      • Injections, Intravenous
      • Lidocaine / pharmacology
      • Lidocaine / therapeutic use
      • Procainamide / pharmacology
      • Procainamide / therapeutic use
      • Propranolol / pharmacology
      • Propranolol / therapeutic use
      • Quinidine / pharmacology
      • Quinidine / therapeutic use

      Citations

      This article has been cited 1 times.
      1. Vitale V, Vezzosi T, Di Franco C, Briganti A, Tognetti R, Conte G, Bucchioni E, Sgorbini M. Equine echocardiography: Can dobutamine infusion correct alterations due to sedation with alpha-2 agonists?. PLoS One 2022;17(10):e0276256.
        doi: 10.1371/journal.pone.0276256pubmed: 36256667google scholar: lookup